Physician profile
Simon Kim
NPI 1407972748
$1,104.53
in general payments reported to CMS, 2019-2025
16 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.99 · 2020: $13.75 · 2022: $208 · 2023: $397 · 2024: $247 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $168.52 | 2023-2024 | Ams 700 |
| Intuitive Surgical, INC. | $159.85 | 2020-2022 | |
| Axonics, INC. | $146.15 | 2023 | Axonics, Bulkamid |
| Olympus America INC. | $141.39 | 2023-2025 | Itind System |
| Karl Storz Endoscopy-America | $75.70 | 2024 | Hopkins |
| Sumitomo Pharma America, INC. | $66.16 | 2024-2025 | Orgovyx, Gemtesa |
| Innovation Technologies INC | $61.73 | 2022 | |
| Urogen Pharma, INC. | $48.83 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $46.33 | 2025 | Adstiladrin |
| Astellas Pharma US INC | $44.99 | 2019 | |
| Becton, Dickinson and Company | $34.27 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $24.40 | 2024 | Lynparza |
| Pfizer INC. | $24.06 | 2025 | |
| Janssen Biotech, INC. | $23.21 | 2024 | Erleada, Akeega |
| Abbvie INC. | $20.90 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $18.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.